Questions to Bring to Your Clinician (So You Get Real Answers) Appointments often fail because the patient describes discomfort but not pattern, triggers, or functional impairment
The absence of effective conventional options increases the relative risk tolerance for an unvalidated compound in the treatment-resistant population
[] Meso-2,3-dimercaptosuccinic acid analogues With the discovery that DMSA possessed fewer negative effects when having a strong therapeutic effect, research has since been directed at developing DMSA analogues which would be more effective and with minimal side effects
The patients were diagnosed using the WHO criteria of post-COVID (long COVID) [52], namely: (a) individuals having a history of proven SARS-CoV-2 infection, (b) symptoms persisted beyond the acute phase of illness or manifested during recovery from acute COVID-19 infection, (c) symptoms lasted at least 2 months and are present 34 months after the onset of COVID-19, and (d) patients suffer from at least two symptoms that impair daily functioning including fatigue, memory or concentration problems, shortness of breath, chest pain, persistent cough, difficulty speaking, muscle aches, loss of smell or taste, affective symptoms, cognitive impairment, or fever [52]
Peprotech Inc, Rocky Hill, NJ), or vehicle (0.9% sterile saline), at P16
Inhibitory control test, critical flicker frequency, and psychometric tests in the diagnosis of minimal hepatic encephalopathy in cirrhosis
